Case Report: Pathological complete response yet early brain relapse in HER2-positive breast cancer: a case-based review
Despite advances in anti-HER2 therapies leading to high pathological complete response (pCR) rates, the blood-brain barrier (BBB) still shelters micrometastatic deposits, so intracranial relapse continues to pose a formidable therapeutic obstacle in HE…